ITI Pharma and Healthcare Fund Regular vs Nippon India Pharma Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹231 Cr | ₹8459 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.35 | 1.82 |
| Manager | Rohan Korde | Sailesh Raj Bhan |
| ISIN Code | INF00XX01BL5 | INF204K01968 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -1.98% | -0.62% |
| 6 Month | -4.22% | -0.93% |
| 1 Year | -10.48% | -3.45% |
| 3 Year | 19.03% | 22.08% |
| 5 Year | - | 14.96% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -2.86% | -0.23% |
| 1 Year | -2.5% | 4.86% |
| 3 Year | 12.43% | 15.43% |
| 5 Year | - | 15.72% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 18.94% | 16.55% |
| 3 Year | 20.21% | 20.97% |
| 5 Year | - | 20.36% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | 14.52% | 14.36% |
| Sharp | 0.81% | 0.98% |
| Beta | 0.89% | 0.87% |
| Alpha | -1.07% | 1.45% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Rohan Korde | Sailesh Raj Bhan |
| Total AUM | ₹4626 Cr | ₹96086 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 2.71 | 0.53 |
| Large Cap | 48.48 | 49.08 |
| Small Cap | 27.6 | 29.6 |
| Mid Cap | 21.21 | 20.79 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 2.71 | 0.53 |
| Pharmaceuticals & Biotechnology | 69.73 | 75.31 |
| Healthcare Services | 22.3 | 20.69 |
| Industrial Manufacturing | 0.97 | - |
| Insurance | 1.26 | - |
| Healthcare Equipment & Supplies | 0.91 | - |
| Fertilizers & Agrochemicals | 1.31 | - |
| Chemicals & Petrochemicals | 0.81 | - |
| Retailing | - | 3.47 |
Top Comparisons
BANDHAN LIQUID Fund - Regular Plan - Growth
3Y Returns6.89%
Invesco India Liquid Fund - Bonus Option
3Y Returns%
BANDHAN Arbitrage Fund - Regular Plan - Growth
3Y Returns6.95%
UTI Arbitrage Fund - Regular Plan - Growth Option
3Y Returns7.13%
ICICI Prudential MidCap Fund - Growth
3Y Returns23.39%
Axis Midcap Fund - Regular Plan - Growth
3Y Returns19.67%
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns10.01%
Edelweiss Equity Savings Fund - Regular Plan - Growth Option
3Y Returns11.4%